PRIMARY OPEN-ANGLE GLAUCOMA
Clinical trials for PRIMARY OPEN-ANGLE GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY OPEN-ANGLE GLAUCOMA trials appear
Sign up with your email to follow new studies for PRIMARY OPEN-ANGLE GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glaucoma patients may get vision boost from common supplements
Disease control OngoingThis study tests whether taking nicotinamide and pyruvate (N&P) supplements can help maintain eye health in people with open-angle glaucoma. About 250 adults aged 35-85 will take N&P or a placebo for 20 months, while continuing their standard glaucoma medications. The goal is to …
Matched conditions: PRIMARY OPEN-ANGLE GLAUCOMA
Phase: PHASE2, PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New implant aims to lower eye pressure when drops fail
Disease control OngoingThis early study tests a new glaucoma drainage implant in 30 adults with open-angle glaucoma that eye drops cannot control or where standard surgery might fail due to scarring. The implant is designed to lower eye pressure by at least 20% at 6 months without increasing the number…
Matched conditions: PRIMARY OPEN-ANGLE GLAUCOMA
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Glaucoma study tracks how vision loss limits Seniors' mobility
Knowledge-focused OngoingThis study looks at how vision loss from glaucoma affects the ability of older adults to move around and go places. Researchers are tracking 88 participants with glaucoma to see how far they travel from home and if dim lighting makes it harder. The goal is to better understand th…
Matched conditions: PRIMARY OPEN-ANGLE GLAUCOMA
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 17, 2026 05:21 UTC